These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10704954)

  • 1. Plasma homovanillic acid in the prodromal phase of schizophrenia.
    Sumiyoshi T; Kurachi M; Kurokawa K; Yotsutsuji T; Uehara T; Itoh H; Saitoh O
    Biol Psychiatry; 2000 Mar; 47(5):428-33. PubMed ID: 10704954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of mental stress on plasma homovanillic acid in schizophrenia and normal controls.
    Sumiyoshi T; Saitoh O; Yotsutsuji T; Itoh H; Kurokawa K; Kurachi M
    Neuropsychopharmacology; 1999 Apr; 20(4):365-9. PubMed ID: 10088137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients.
    Baeza I; Castro-Fornieles J; Deulofeu R; de la Serna E; Goti J; Salvà J; Bernardo M
    Psychiatry Res; 2009 Jul; 168(2):110-8. PubMed ID: 19501918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of mental stress on plasma homovanillic acid in healthy human subjects.
    Sumiyoshi T; Yotsutsuji T; Kurachi M; Itoh H; Kurokawa K; Saitoh O
    Neuropsychopharmacology; 1998 Jul; 19(1):70-3. PubMed ID: 9608578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma homovanillic acid in untreated schizophrenia--relationship with symptomatology and sex.
    Zhang ZJ; Peet M; Ramchand CN; Shah S; Reynolds GP
    J Psychiatr Res; 2001; 35(1):23-8. PubMed ID: 11287053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma HVA in psychiatric patients: longitudinal studies.
    Javaid JI; Sharma RP; Janicak PG; Davis JM
    Psychopharmacol Bull; 1990; 26(3):361-5. PubMed ID: 2274637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma homovanillic acid levels in first-episode schizophrenia. Psychopathology and treatment response.
    Koreen AR; Lieberman J; Alvir J; Mayerhoff D; Loebel A; Chakos M; Amin F; Cooper T
    Arch Gen Psychiatry; 1994 Feb; 51(2):132-8. PubMed ID: 7905259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma HVA, tardive dyskinesia and psychotic symptoms in long-term drug-free inpatients with schizophrenia.
    Muscettola G; Barbato G; de Bartolomeis A; Monteleone P; Pickar D
    Psychiatry Res; 1990 Sep; 33(3):259-67. PubMed ID: 2243901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability of plasma homovanillic acid over 13 months in patients with schizophrenia; relationship with the clinical response and the Wisconsin card sort test.
    Zumárraga M; González-Torres MA; Arrue A; Dávila R; Dávila W; Inchausti L; Pérez-Cabeza L; Fernández-Rivas A; Bustamante S; Basterreche N; Guimón J
    Neurochem Res; 2011 Aug; 36(8):1336-43. PubMed ID: 21475956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in plasma homovanillic acid levels in schizophrenia and normal controls: relation to neuroleptic resistance.
    Sumiyoshi T; Hasegawa M; Jayathilake K; Meltzer HY
    Biol Psychiatry; 1997 Mar; 41(5):560-6. PubMed ID: 9046988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of plasma homovanillic acid concentrations in schizophrenic patients.
    Kaminski R; Powchick P; Warne PA; Goldstein M; McQueeney RT; Davidson M
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(3):271-87. PubMed ID: 2193315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABA and homovanillic acid in the plasma of Schizophrenic and bipolar I patients.
    Arrúe A; Dávila R; Zumárraga M; Basterreche N; González-Torres MA; Goienetxea B; Zamalloa MI; Anguiano JB; Guimón J
    Neurochem Res; 2010 Feb; 35(2):247-53. PubMed ID: 19701707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of changes in memory performance by plasma homovanillic acid levels in clozapine-treated patients with schizophrenia.
    Sumiyoshi T; Roy A; Kim CH; Jayathilake K; Lee MA; Sumiyoshi C; Meltzer HY
    Psychopharmacology (Berl); 2004 Dec; 177(1-2):79-83. PubMed ID: 15179543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of symptomatology, gender, and antipsychotic drug treatment with plasma homovanillic acid in schizophrenia.
    Zhang ZJ; Reynolds GP; Ramchand C; Peet M; Shah S
    Acta Pharmacol Sin; 2001 Jan; 22(1):76-80. PubMed ID: 11730567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma homovanillic acid and treatment response in a large group of schizophrenic patients.
    Chang WH; Hwu HG; Chen TY; Lin SK; Lung FW; Chen H; Lin WL; Hu WH; Lin HN; Chien CP
    Schizophr Res; 1993 Oct; 10(3):259-65. PubMed ID: 8260444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma HVA levels following debrisoquine administration do not reflect cerebral dopamine loss in early Parkinson's disease.
    Rose S; Hindmarsh JG; Steiger MJ; Bhatt M; Quinn NP; Jenner P; Marsden CD
    Clin Neuropharmacol; 1994 Jun; 17(3):260-9. PubMed ID: 9316671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment plasma homovanillic acid in schizophrenia and schizoaffective disorder: the influence of demographic variables and the inpatient drug-free period.
    Sharma RP; Javaid JI; Davis JM; Janicak PG
    Biol Psychiatry; 1998 Sep; 44(6):488-92. PubMed ID: 9777181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of plasma homovanillic acid in the deficit and nondeficit subtypes of schizophrenia.
    Ribeyre JM; Lesieur P; Varoquaux O; Dollfus S; Pays M; Petit M
    Biol Psychiatry; 1994 Aug; 36(4):230-6. PubMed ID: 7986887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with clozapine and its effect on plasma homovanillic acid and norepinephrine concentrations in schizophrenia.
    Davidson M; Kahn RS; Stern RG; Hirschowitz J; Apter S; Knott P; Davis KL
    Psychiatry Res; 1993 Feb; 46(2):151-63. PubMed ID: 8483974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma homovanillic acid levels in schizophrenic patients: correlation with negative symptoms.
    Dávila R; Zumárraga M; Basterreche N; Arrúe A; Anguiano JB
    Psychiatry Res; 2007 May; 151(1-2):163-8. PubMed ID: 17434602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.